The Italian Registry of Malnutrition in Oncology
Multicentric, Observational, Longitudinal Study for the Evaluation of Nutritional Management Implications in Newly Diagnosed Italian Cancer Patients: The Italian Registry of Malnutrition in Oncology (IRMO)
Fondazione IRCCS Policlinico San Matteo di Pavia
1,500 participants
Oct 25, 2022
OBSERVATIONAL
Conditions
Summary
The aim of the Italian Registry of Malnutrition in Oncology (IRMO) is to set up a digital register of newly diagnosed or treated oncologic patients to monitor their nutritional status, early identify malnutrition and investigate the implications of nutritional support management. In particular, this project aims to establish a prospective cohort of cancer patients in order to investigate the effects of nutritional status and management on overall survival (OS) and progression free survival (PFS), and analyse the effects of the nutritional management and support on patients' symptoms and QoL.
Eligibility
Inclusion Criteria4
- Aged ≥18 years;
- New diagnosis of the following cancers: head and neck, oesophagus/stomach, colorectal, hepato-biliary, pancreatic, lung, prostate, other urogenital, breast, gynaecological and, soft tissue sarcomas and melanomas; patients with a new diagnosis of metastatic disease will be also included;
- Eligible for active treatment;
- Written informed consent to participate in the study.
Exclusion Criteria2
- Impossibility to undertake the expected measurements;
- Impossibility to guarantee the attendance of the follow-up visits.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Cohort observational
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06337019